|
Characteristic
|
Patients (N = 58)
|
|---|
|
Sex
| |
|
• Male
|
36 (62.1%)
|
|
• Female
|
22 (37.9%)
|
|
Median Age [y]
|
52 (18 – 68)
|
|
MGMT methylation status
| |
|
• Methylated
|
20 (34.5%)
|
|
• Not methylated
|
28 (48.3%)
|
|
• Unknown
|
10 (17.2%)
|
|
Surgery
| |
|
• Yes
|
47 (81%)
|
|
• No
|
11 (19%)
|
|
WHO grade at relapse
| |
|
• III
|
12 (20.7%)
|
|
• IV
|
46 (79.3%)
|
|
KPS
|
Median 80
|
|
• < 70
|
14 (24.1%)
|
|
• ≥ 70
|
44 (75.9%)
|
|
Brachytherapy
| |
|
• Yes
|
8 (13.8%)
|
|
• No
|
50 (86.2%)
|
- All MG patients (N = 58) had received radiotherapy with median 60 Gy as a postoperative or primary therapy before.
